Search results
Results from the WOW.Com Content Network
Famotidine, sold under the brand name Pepcid among others, is a histamine H 2 receptor antagonist medication that decreases stomach acid production. [4] It is used to treat peptic ulcer disease, gastroesophageal reflux disease, and Zollinger-Ellison syndrome. [4] It is taken by mouth or by injection into a vein. [4] It begins working within an ...
The syndrome can occur at the beginning of treatment for eating disorders when patients have an increase in calorie intake and can be fatal. It can also occur when someone does not eat for several days at a time usually beginning after 4–5 days with no food. [5] It can also occur after the onset of a severe illness or major surgery. The ...
Dysphagia can happen at any age, with about 1 in 25 U.S. adults experiencing it every year, Dr. Abu-Ghanem says. It’s more common in older adults. It’s more common in older adults.
Mast cell activation syndrome (MCAS) is a term referring to one of two types of mast cell activation disorder (MCAD); the other type is idiopathic MCAD. [1] MCAS is an immunological condition in which mast cells, a type of white blood cell, inappropriately and excessively release chemical mediators, such as histamine, resulting in a range of chronic symptoms, sometimes including anaphylaxis or ...
Cases of norovirus, a.k.a. the stomach bug, are surging in the U.S. right now. There is no specific medication to treat norovirus. Doctors share tips for feeling better, sooner. The U.S. is seeing ...
About 900 people die of norovirus every year (mostly patients over the age of 65), and 109,000 people are hospitalized with it, reports the American Medical Association.
stomach, whereas going out to eat typically occurs when one is hungry, and generally requires the consumer to make only one immediate meal choice. Consumers who are hungry and anticipating a quick meal may be more short-sighted and less motivated to engage in the effortful processing required to use nutritional information (George Loewenstein ...
The number of people who get anaphylaxis is 4–100 per 100,000 persons per year, [10] [54] with a lifetime risk of 0.05–2%. [55] About 30% of affected people get more than one attack. [ 54 ] Exercise-induced anaphylaxis affects about 1 in 2000 young people.